Mechanisms of early death despite thrombolytic therapy: Experience from the Thrombolysis in Myocardial Infarction Phase II (TIMI II) study

This publication has 18 references indexed in Scilit:

• Results of primary angioplasty for acute myocardial infarction in patients with multivessel coronary artery disease
  Journal of the American College of Cardiology, 1990
• Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator
  Journal of the American College of Cardiology, 1989
• Coronary angioplasty as primary therapy for acute myocardial infarction 6 to 48 hours after symptom onset: Report of an initial experience
  Journal of the American College of Cardiology, 1989
• Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
  New England Journal of Medicine, 1989
• The German multicenter trial of anisoylated plasminogen streptokinase activator complex versus heparin for acute myocardial infarction
  The American Journal of Cardiology, 1988
• Coronary perfusion during acute myocardial infarction with a combined therapy of coronary angioplasty and high-dose intravenous streptokinase.
  Circulation, 1988
• THROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTY
  The Lancet, 1988
• A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
  New England Journal of Medicine, 1987
• Progressive nature of myocardial injury in selected patients with cardiogenic shock
  The American Journal of Cardiology, 1978
• Pathophysiology of Cardiogenic Shock
  Circulation, 1973